4.6 Editorial Material

Targeting a Hallmark of Crohn's Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation?

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Characteristics of mesenteric adipose tissue attached to different intestinal segments and their roles in immune regulation

Haowei Zhang et al.

Summary: This study reveals the differences between mesenteric adipose tissue (MAT) adjacent to the small and large intestines in terms of morphology, gene expression, cell components, and immune and microbiota regulation. These findings will guide future research to investigate the specialized roles of different MATs in intestinal health and disease.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2022)

Article Gastroenterology & Hepatology

Role of the Mesentery in Crohn's Terminal Ileitis

Marte A. J. Becker et al.

Summary: The presence of mesenteric alterations in Crohn's disease has long been acknowledged, but their functional and clinical consequences remain debatable. Guidelines recommend limited resection without removal of adjacent mesentery to prevent complications, but recent studies propose mesenteric resection as an alternative to reduce disease recurrence in Crohn's patients.

CLINICS IN COLON AND RECTAL SURGERY (2022)

Review Endocrinology & Metabolism

Beige Adipose Tissue Identification and Marker Specificity-Overview

Anna-Claire Pilkington et al.

Summary: Adipose tissue is classified based on its characteristics, but differentiating beige adipose tissue (BeAT) remains a challenge. Recent research focuses on identifying different types of adipose tissue through transcript markers to advance understanding of their biology. The development of concrete strategies to distinguish types of adipose tissue may be crucial for improving metabolic health and preventing excessive weight gain.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Biochemistry & Molecular Biology

Role of Adipose Tissue in Inflammatory Bowel Disease

Eva Karaskova et al.

Summary: Inflammatory bowel diseases (IBDs), such as Crohn's disease and ulcerative colitis, are chronic inflammatory disorders affecting the gastrointestinal tract. Obesity, particularly visceral adiposity, plays a significant role in the pathogenesis of IBD, influencing disease severity and clinical outcomes. Visceral adipose tissue is actively involved in lipid storage, immunological and endocrine activity, serving as a barrier to inflammation and potentially the main source of cytokines and adipokines associated with IBD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Serum adipokines as non-invasive biomarkers in Crohn's disease

Lorena Ortega Moreno et al.

SCIENTIFIC REPORTS (2020)

Review Medicine, General & Internal

Pathophysiology of Inflammatory Bowel Diseases

John T. Chang

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

Adipokines and Their Role in Intestinal Inflammation

Carl Weidinger et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Gastroenterology & Hepatology

The mesentery: structure, function, and role in disease

J. Calvin Coffey et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Immunology

Mesenteric fat-control site for bacterial translocation in colitis?

A. Batra et al.

MUCOSAL IMMUNOLOGY (2012)